Showing results (81-90 of 217) with videos related to
Sort By:
Pageof 22
Clinical Lung Cancer|August 16, 2005
Wnt signaling in stem cells and non-small-cell lung cancerBiao He, Richard N Barg, Liang You, et al.Oncogene|March 1, 2005
Blockade of Wnt-1 signaling induces apoptosis in human colorectal cancer cells containing downstream mutationsBiao He, Noemi Reguart, Liang You, et al.Lung Cancer (Amsterdam, Netherlands)|September 15, 2019
Current management of limited-stage SCLC and CONVERT trial impact: Results of the EORTC Lung Cancer Group surveyAntonin Levy, Lizza E L Hendriks, Cécile Le Péchoux, et al.Lung Cancer (Amsterdam, Netherlands)|August 10, 2018
What you see is (not) what you get: tools for a non-radiologist to evaluate image quality in lung cancerEvelyn E C de Jong, Lizza E L Hendriks, Wouter van Elmpt, et al.Clinical Lung Cancer|September 20, 2024
Association of Serum Biomarkers With Neurocognitive Decline After PCI in Small Cell Lung Cancer: An Exploratory Study of the Phase III NCT01780675 TrialHaiyan Zeng, Lizza E L Hendriks, José Belderbos, et al.Cancer Treatment Reviews|January 3, 2026
Intracranial activity of antibody-drug conjugates in advanced non-small cell lung cancer: What have we accomplished so far?Seng Wee Cheo, Molly S C Li, Derek De-Rui Huang, et al.Neuro-Oncology Practice|August 15, 2025
Screening for brain metastases in patients with advanced non-small cell lung cancer and an actionable genomic alteration: A structured literature reviewJarno W J Huijs, Martina Bortolot, Anna S Berghoff, et al.Journal of Cachexia, Sarcopenia and Muscle|January 11, 2022
Physical exercise at the crossroad between muscle wasting and the immune system: implications for lung cancer cachexiaFrancesco Cortiula, Lizza E L Hendriks, Wouter R P H van de Worp, et al.Lung Cancer (Amsterdam, Netherlands)|May 11, 2026
Upfront management of brain metastases in oncogene‑addicted NSCLC - An EORTC surveyAna Ortega-Franco, Ilias Houda, Mariana Brandão, et al.Oncology (Williston Park, N.Y.)|January 20, 2005
The promise of pharmacogenomics: gemcitabine and pemetrexedRafael Rosell, Miquel Taron, Jose Miguel Sanchez, et al.Pageof 22